Closed
Licence variation: spironolactone for acne in women
Request tender documents
Save your time. You just request and we will send you the available documents.
Request for bid service
Save your time. You just request and we will arrange tender related all available documents to bid writers for the best possible quote.
Descriptions
NHS England required a supplier to apply for a major (type II) MHRA Marketing Authorisation variation for spironolactone. The variation is to add a new indication to the current licence (marketing authorisation) for treating acne in women. The Successful Supplier would need to prepare a dossier for the MHRA including a Risk Management Plan, apply for the licence variation, and if granted update their licence, Summary of Product Characteristics and patient information leaflet with the new indication and related data.
Timeline
Published Date :
Deadline :
Contract Start :
Contract End :
Tender Regions
CPV Codes
85100000 - Health services
Keywords
hospitalization
outpatient care
medical services
patient care provision
diagnostic services
health assessments
specialist consultations
therapeutic treatments
clinical healthcare
preventive health services
Tender Lot Details & Award Criteria
1 Tender Lots
Workflows
Status :
Procedure :
Suitable for SME :
Nationwide :
Assign to :
Tender Progress :
Details
Notice Type :
Buyer Information
Name :
